| Symbol | FNNZF |
|---|---|
| Name | FINCANNA CAPITAL CORP. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | V6C 2V6 Canada BC Suite 550 - 800 West Pender St. |
| Telephone | 778-327-5799 |
| Fax | — |
| — | |
| Website | https://www.fincannacapital.com |
| Incorporation | CA |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 4/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Davidson & Company LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Foreign Issuer - Not Listed on Foreign Exchange |
| CIK | 0001710509 |
| Description | FinCanna Capital Corp. is a royalty company for the licensed medical cannabis industry which invests in sizable and scalable best-in-class businesses. The Issuers business objective is to provide capital solutions to companies in the medical cannabis industry with large scale potential, a highly skilled and experienced operator, which plan to produce high value, high demand licensed medical products or related products and services. Additional info from OTC: |
No news found.